282 related articles for article (PubMed ID: 25378432)
21. Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia.
Li P; Mao L; Zhou G; Leak RK; Sun BL; Chen J; Hu X
Stroke; 2013 Dec; 44(12):3509-15. PubMed ID: 24092548
[TBL] [Abstract][Full Text] [Related]
22. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
[TBL] [Abstract][Full Text] [Related]
23. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice.
Rosenzweig HL; Lessov NS; Henshall DC; Minami M; Simon RP; Stenzel-Poore MP
Stroke; 2004 Nov; 35(11):2576-81. PubMed ID: 15375302
[TBL] [Abstract][Full Text] [Related]
24. Infiltration and persistence of lymphocytes during late-stage cerebral ischemia in middle cerebral artery occlusion and photothrombotic stroke models.
Feng Y; Liao S; Wei C; Jia D; Wood K; Liu Q; Wang X; Shi FD; Jin WN
J Neuroinflammation; 2017 Dec; 14(1):248. PubMed ID: 29246244
[TBL] [Abstract][Full Text] [Related]
25. Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist Stimulation.
Langenhorst D; Tabares P; Gulde T; Becklund BR; Berr S; Surh CD; Beyersdorf N; Hünig T
Front Immunol; 2017; 8():1985. PubMed ID: 29441059
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia.
Brea D; Agulla J; Rodríguez-Yáñez M; Barral D; Ramos-Cabrer P; Campos F; Almeida A; Dávalos A; Castillo J
J Cell Mol Med; 2014 Aug; 18(8):1571-9. PubMed ID: 24889329
[TBL] [Abstract][Full Text] [Related]
27. ACC1 (Acetyl Coenzyme A Carboxylase 1) Is a Potential Immune Modulatory Target of Cerebral Ischemic Stroke.
Wang X; Zhou Y; Tang D; Zhu Z; Li Y; Huang T; Müller R; Yu W; Li P
Stroke; 2019 Jul; 50(7):1869-1878. PubMed ID: 31177975
[TBL] [Abstract][Full Text] [Related]
28. Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.
Tabares P; Berr S; Römer PS; Chuvpilo S; Matskevich AA; Tyrsin D; Fedotov Y; Einsele H; Tony HP; Hünig T
Eur J Immunol; 2014 Apr; 44(4):1225-36. PubMed ID: 24374661
[TBL] [Abstract][Full Text] [Related]
29. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
[TBL] [Abstract][Full Text] [Related]
30. The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke.
Xiao W; Guo S; Chen L; Luo Y
J Neuroimmunol; 2019 Aug; 333():576970. PubMed ID: 31146104
[TBL] [Abstract][Full Text] [Related]
31. Role of Neutrophils in Exacerbation of Brain Injury After Focal Cerebral Ischemia in Hyperlipidemic Mice.
Herz J; Sabellek P; Lane TE; Gunzer M; Hermann DM; Doeppner TR
Stroke; 2015 Oct; 46(10):2916-25. PubMed ID: 26337969
[TBL] [Abstract][Full Text] [Related]
32. CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats.
Miyasato K; Takabatake Y; Kaimori J; Kimura T; Kitamura H; Kawachi H; Li XK; Hünig T; Takahara S; Rakugi H; Isaka Y
Clin Exp Nephrol; 2011 Feb; 15(1):50-7. PubMed ID: 21076989
[TBL] [Abstract][Full Text] [Related]
33. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
[TBL] [Abstract][Full Text] [Related]
34. Adoptive regulatory T-cell therapy protects against cerebral ischemia.
Li P; Gan Y; Sun BL; Zhang F; Lu B; Gao Y; Liang W; Thomson AW; Chen J; Hu X
Ann Neurol; 2013 Sep; 74(3):458-71. PubMed ID: 23674483
[TBL] [Abstract][Full Text] [Related]
35. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
36. Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Poittevin M; Deroide N; Azibani F; Delcayre C; Giannesini C; Levy BI; Pocard M; Kubis N
J Neuroimmunol; 2013 Jan; 254(1-2):55-62. PubMed ID: 23026222
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Caso JR; Pradillo JM; Hurtado O; Lorenzo P; Moro MA; Lizasoain I
Circulation; 2007 Mar; 115(12):1599-608. PubMed ID: 17372179
[TBL] [Abstract][Full Text] [Related]
38. C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke.
Li P; Wang L; Zhou Y; Gan Y; Zhu W; Xia Y; Jiang X; Watkins S; Vazquez A; Thomson AW; Chen J; Yu W; Hu X
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28768648
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke.
Liu X; Hu R; Pei L; Si P; Wang C; Tian X; Wang X; Liu H; Wang B; Xia Z; Xu Y; Song B
Exp Neurol; 2020 Jun; 328():113233. PubMed ID: 32044328
[TBL] [Abstract][Full Text] [Related]
40. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.
Malone K; Diaz Diaz AC; Shearer JA; Moore AC; Waeber C
J Neuroinflammation; 2021 Jan; 18(1):37. PubMed ID: 33516262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
